Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
102.6 USD | +0.13% | -0.08% | -6.14% |
04-30 | TD Cowen Adjusts Price Target on Revvity to $130 From $123 | MT |
04-30 | JPMorgan Adjusts Price Target on Revvity to $105 From $100, Neutral Rating Maintained | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.14% | 12.66B | |
+8.33% | 217B | |
+6.72% | 183B | |
+10.18% | 131B | |
+24.91% | 106B | |
-0.95% | 62.16B | |
+10.56% | 51.02B | |
+4.81% | 50.89B | |
-0.24% | 40.16B | |
+1.22% | 34.79B |
- Stock Market
- Equities
- RVTY Stock
- News Revvity, Inc.
- PerkinElmer : Receives FDA Emergency Use Authorization for COVID-19 Assay